 |
 |
|
|
 |
Commentaires de nos clients |
|
|
| Liste des catégories |
Articolo |
News |
 |
| |
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years. - The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth. - Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure. - Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people. - Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.

Remboursementgaranti
Achatsécurisé
Notre page de facturation est certifiée par:
- Rare Canadian pharmacy takeover is inked - Globe and Mail
Globe and MailRare Canadian pharmacy takeover is inkedGlobe and MailIn Canada, you don't see health-and-drug-related M&A very often, and you especially don't hear about deals for independent pharmacies that are worth almost $1-billion. - McKesson Buys Canadian Pharmacy Marketing Group Assets for $918 Million - Bloomberg
CTV. - Medavie website compares drug prices - CBC.ca
CBC. - Shoppers downgraded as independent pharmacies stay afloat - Financial Post
Financial PostShoppers downgraded as independent pharmacies stay afloatFinancial PostInterestingly, new entrant Target, coming to Canada in 2013, will replace the pharmacies in current Zellers locations with a franchise model. - Metro to remain in the mix despite heightened Canadian pharmacy competition - GlobalNews.ca
Metro to remain in the mix despite heightened Canadian pharmacy competitionGlobalNews.
|
|
|
 |
|
|